NCT01051076 - Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 3, 2009

Primary Completion Date

October 21, 2020

Study Completion Date

October 21, 2020

Conditions

Severe Hemophilia A

Interventions

DRUG

VWF/FVIII concentrates

200 IU/Kg by one or two bolus injections daily. After successful confirmation the dose will be tailed off progressively until discontinuation. Patients will be treated with a VWF/FVIII concentrates according to physician/patients preference.

Trial Locations (1)

91010

City of Hope Medical Center, Duarte